Luye Pharma Group Ltd. (HKG:2186)
Hong Kong · Delayed Price · Currency is HKD 2.230
+0.060 (2.76%)
Jun 1, 2026, 4:08 PM HKT
Luye Pharma Group Revenue
In the year 2025, Luye Pharma Group had annual revenue of 6.31B CNY with 4.07% growth. Luye Pharma Group had revenue of 3.13B in the half year ending December 31, 2025, a decrease of -3.45%.
Revenue
6.31B CNY
Revenue Growth
+4.07%
P/S Ratio
1.27
Revenue / Employee
1.21M CNY
Employees
5,221
Market Cap
8.91B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.31B | 246.93M | 4.07% |
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsLuye Pharma Group News
- 2 months ago - Luye Pharma Group Earnings release: H2 2025 - Filings
- 9 months ago - Luye Pharma Group Earnings release: H1 2025 - Filings
- 9 months ago - Luye Pharma Group Quarterly report: H1 2025 - Filings
- 1 year ago - Luye Pharma upgraded to Neutral from Sell at Goldman Sachs - TheFly